Both the chick myopia susceptibility GWAS and the human GWAS gene-based tests provided the strongest support for the involvement of the
PIK3CG and
PRKAR2B genes, which both have functions related to cAMP signaling.
48 Notably, the phosphoinositide 3-kinase (PI3K) signaling axis has been implicated in previous studies of refractive development. Specifically,
PRKAR2B gene expression in the retina was found to be upregulated 1.7-fold in chicks wearing +7 D lenses for 24 hours,
49 and the PI3K inhibitor Ly294002 was shown to prevent the exaggerated response to negative lens wear in chicks treated with intravitreal insulin.
50 Therefore, attention was focused on the
PIK3CG and
PRKAR2B genes. To visualize the enrichment of GWAS markers associated with
PIK3CG and
PRKAR2B, QQ plots and regional association plots were created for the CREAM GWAS summary statistics, the UKEV GWAS summary statistics, and a meta-analysis of the two GWAS datasets (
Fig. 3;
Supplementary Fig. S2). As expected from the gene-based test results, the QQ plots confirmed that there was an excess of markers with low
P values compared with what would be expected under the null hypothesis of no association, including when only markers selected as being in linkage equilibrium were considered (note that this selection of markers in linkage equilibrium was done without reference to any phenotypic information). The regional association plots (
Supplementary Fig. S2) suggested that markers associated with refractive error in human participants were distributed across a broad region of low recombination rate encompassing
PIK3CG,
PRKAR2B, and the intergenic region between them. The most strongly associated marker differed in the following three GWAS datasets: the lead markers were intergenic variant rs17153745 in the CREAM GWAS, rs757903 in the promoter region of
PIK3CG in the UKEV GWAS, and rs117909394 situated within the coding region of
PRKAR2B in the meta-analysis of the CREAM and UKEV GWAS.
Table 2 summarizes the level of association with refractive error in each of the three GWAS datasets, for these three markers. Attempts to fine-map the region using a Bayesian approach
45 that evaluated the evidence for between 1 and 5 causal variants in the region consistently provided evidence favoring multiple causal variants rather than a single causal variant. However, it was not possible to confidently select a set of potentially causal markers, perhaps due to the low level of recombination across the
PIK3CG-
PRKAR2B region.